Keratosis, Actinic: all 369 studies
Page 3 of 4. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.
- Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Actinic KeratosisStatus unknownNCT04396184Not applicable
- Study of Metabolic Changes in the Transformation Malignant Precancerous Skin LesionsCompletedNCT04389112Not applicable
- Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant RecipientsWithdrawnNCT04329221Phase 2
- Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization StudyTerminatedNCT04249115Not applicable
- Portable Measurement of Protoporphyrin IX in the SkinCompletedNCT04223570
- TreatMent of ActInic KerAtosis Lesions : pharmacoepiDemiological Study of the Impact in Real Life of ingenOl Mebutate Gel (Picato®) on Patients SatisfactionCompletedNCT04202445
- Treatment of Actinic Keratosis With 5% KOH SolutionCompletedNCT04024579
- Combination Topical Therapy for Treatment of Scalp Actinic KeratosesTerminatedNCT03996252Early Phase 1
- Duration of Ameluz Application in Acral Actinic Keratoses ResponseTerminatedNCT03963102Phase 4
- Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic KeratosisCompletedNCT03826550Phase 3
- Indoor Daylight Photo Dynamic Therapy for Actinic KeratosisCompletedNCT03805737Not applicable
- Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic KeratosisCompletedNCT03731988Phase 4
- Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) CreamCompletedNCT03727074Phase 3
- Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior CurettageCompletedNCT03697590Phase 4
- Topical Ionic Contra-Viral Therapy in Actinic KeratosisStatus unknownNCT03684772Phase 2
- 5-ALA Patch-PDT of Actinic Keratosis on the Upper ExtremitiesCompletedNCT03606122Phase 2
- The Study of Plum-blossom Needling Enhancing Efficacy of Aminolevulinic Acid-photodynamic Therapy for Actinic KeratosisStatus unknownNCT03596619Not applicable
- Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic KeratosisCompletedNCT03575780Phase 1
- Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged SkinCompletedNCT03508856Not applicable
- Treatment of Plantar Keratosis With Medicinal Plant in Diabetic PatientsCompletedNCT03447925Phase 2
- Efficacy in Ablative Fractional Laser Assisted Photodynamic Therapy According to Ablative Depth for Actinic KeratosisCompletedNCT03325803Phase 1
- Biomarker Database Registry for Photodynamic TherapyCompletedNCT03319251
- Evaluating Skin Appearance Following 5-Flourouracil Cream for Treatment of Actinic Keratosis and the Effects of Topical AgentsCompletedNCT03279328Phase 4
- Nevus Doctor Clinical Decision Support for GPsCompletedNCT03246412Not applicable
- Cosmetic Study of AO+Mist in Improving the Appearance of Skin Afflicted With Keratosis PilarisCompletedNCT03243617Not applicable
- Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic KeratosisCompletedNCT03210740Phase 2
- DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant RecipientsCompletedNCT03110159Phase 1/2
- Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic TherapyCompletedNCT03076918Not applicable
- Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOSCompletedNCT03076892Not applicable
- Photodynamic Therapy Incubation Times for Actinic KeratosisCompletedNCT03066843Not applicable
- Phase 3 Study of Levulan With New Blue Light for AK on the Face or ScalpWithdrawnNCT03024060Phase 3
- Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field CancerizationStatus unknownNCT03013647Not applicable
- Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization vs CryotherapyCompletedNCT02990221Phase 4
- Menthol for PDT Pain ReliefCompletedNCT02984072Phase 4
- Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic KeratosisCompletedNCT02976727Phase 1
- Pilot Study of the Pragmatic Use of Mobile Phone Based Follow up of Actinic Keratoses Treated With Topical 5-fluorouracilCompletedNCT02938715Not applicable
- Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of BergamoCompletedNCT02902822Not applicable
- Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United StatesWithdrawnNCT02867722Not applicable
- A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its PrecursorsWithdrawnNCT02813902Phase 1
- A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic KeratosisCompletedNCT02799030Phase 2
- Using a Cold Atmospheric Plasma Device to Treat Skin DisordersStatus unknownNCT02759900Not applicable
- Tobacco Cessation Intervention Study for Oral DiseasesStatus unknownNCT02737176Not applicable
- Daylight-PDT With MAL for AK and Photodamaged SkinCompletedNCT02736760Phase 4
- Metvix Daylight PDT in Actinic KeratosisCompletedNCT02674048
- Efficacy of Iontophoresis-assisted AFL-PDT in Actinic KeratosisCompletedNCT02670655Phase 1
- A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 GelCompletedNCT02650505Phase 1
- Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA GelStatus unknownNCT02647151Phase 4
- Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation ProtocolCompletedNCT02644187Not applicable
- Bilateral Comparison of Treatment of Facial Actinic Keratoses Using Microneedling and Photodynamic Therapy With Aminolevulinic Acid and Blue Light Versus Photodynamic Therapy With Aminolevulinic Acid and Blue Light Using Two Incubation TimesCompletedNCT02622594Phase 4
- A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald ScalpCompletedNCT02611804Phase 3
- Biological Effects of LEO 43204 in Actinic KeratosisCompletedNCT02600598Phase 1
- The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical PracticeCompletedNCT02594436
- Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic KeratosisCompletedNCT02559934Phase 1
- A Comparison of White-light and Daylight Topical Methyl 5-aminolaevulinic Acid Photodynamic Therapy for Actinic KeratosesCompletedNCT02520700Not applicable
- Ingenol Mebutate Gel 0.05% in Kidney Transplant Recipients With Actinic KeratosesTerminatedNCT02473848Phase 3
- Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)CompletedNCT02464709Phase 4
- A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic TherapyCompletedNCT02451579Not applicable
- Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use ConditionsCompletedNCT02424305Phase 1
- PMS to Evaluate the Safety and Efficacy of Picato® GelCompletedNCT02421471
- Treatment of Actinic Keratoses (AK) on the FaceCompletedNCT02411851Phase 1
- Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or ScalpCompletedNCT02406014Phase 4
- Electrocautery vs Q-switch for Seborrheic KeratosisWithdrawnNCT02366559Not applicable
- The Real Life Topical Field Treatment of Actinic Keratosis StudyCompletedNCT02362152
- Ingenol Mebutate (Picato®) With Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic KeratosisStatus unknownNCT02354391Phase 2
- Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic KeratosisCompletedNCT02337205Phase 1
- Open Uncontrolled Validation Study for the German Version of the Actinic Keratosis Quality of Life Questionnaire (AKQoL)CompletedNCT02325661Not applicable
- Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic KeratosesCompletedNCT02289768Phase 3
- IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic KeratosisStatus unknownNCT02281682Phase 4
- Oral Isotretinoin Versus Topical Tretinoin for Actinic KeratosisCompletedNCT02278861Phase 2
- Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic KeratosisCompletedNCT02248298Phase 1
- Safety and Tolerability Study of Ingenol Mebutate Compared to 5-FU to Treat Facial Actinic KeratosisCompletedNCT02242747Not applicable
- Twelve Month Follow-Up of CP0108CompletedNCT02209012
- Protocols for Painless Photodynamic Therapy (PDT) of Actinic KeratosesCompletedNCT02124733Phase 3
- Pharmacokinetics of Ingenol Mebutate Gel in Actinic Keratosis Under Maximum Use ConditionsCompletedNCT02124239Phase 1
- Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 WeeksCompletedNCT02090465
- Clinical Study Assessment of SR-T100 Topical Gel Against Actinic KeratosisCompletedNCT02085395Phase 2
- Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational VideoCompletedNCT02062853Not applicable
- Pharmacokinetic Study of Solamargine in Patients With Actinic KeratosisCompletedNCT02029066Phase 1
- Actinic Keratosis StudyCompletedNCT02019355Early Phase 1
- Effects of Topical Diclofenac on Tumor MetabolismCompletedNCT01935531Phase 4
- Evaluation of a Topical Treatment for Actinic KeratosisCompletedNCT01921907Phase 2
- Nanocytology Test to Evaluate Skin Cancer in High Risk PatientsCompletedNCT01905891Not applicable
- Fractional Laser-assisted Daylight Photodynamic Therapy Versus Daylight Photodynamic for Treatment of Actinic KeratosesCompletedNCT01898936Not applicable
- Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%CompletedNCT01892137Phase 1
- Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and ScalpCompletedNCT01836367Phase 1
- Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the ForearmCompletedNCT01803477Phase 1/2
- Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.CompletedNCT01788007Phase 1
- Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic KeratosisCompletedNCT01757613Phase 2
- Effect of Spirulina on Zinc, Vitamin E and Linoleic Acid Levels in Palm Skin Following Chronic Exposure to ArsenicCompletedNCT01752972Not applicable
- Effectiveness of Garlic Oil in the Treatment of Arsenical Palmer KeratosisCompletedNCT01748669Phase 2
- A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic KeratosisCompletedNCT01742663Phase 1
- Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin LesionsWithdrawnNCT01735942Early Phase 1
- Effect of Nigella Sativa in the Treatment of Palmer Arsenical KeratosisCompletedNCT01735097Not applicable
- Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical KeratosisCompletedNCT01731756Not applicable
- Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic KeratosisCompletedNCT01703078Phase 1
- Long Term Efficacy and Safety of Eryfotona AK-NMSC® in Patients With Actinic KeratosisStatus unknownNCT01656226Phase 4
- Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the HeadCompletedNCT01611480Phase 2
- Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis LesionsCompletedNCT01583816Phase 2
- Photodynamic Therapy of Actinic Keratoses With Alacare®CompletedNCT01571336
- Photodynamic Treatment of Actinic Keratoses With Different Light DosesCompletedNCT01541228Not applicable